High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a m...
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Migraine and depression are highly prevalent and partly overlapping disorders that cause strong limitations in daily life. Patients tend to respond poorly to the therapies available for these diseases. OnabotulinumtoxinA has been proven to be an effective treatment for both migraine and depression. While many studies have addressed the effect of on...
Alternative Titles
Full title
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_03032ccf96e04212a8bb09a1da14db3c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_03032ccf96e04212a8bb09a1da14db3c
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-021-02801-w
